ExoCoBio
PrivateLast Round
Series C
Aug 25, 2020
Total Funding Raised
$47M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ExoCoBio operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in August 2020.
ExoCoBio is a biotechnology company that develops exosome-based biopharmaceuticals and regenerative aesthetic products for skin and hair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExoCoBio Comparables
Compare ExoCoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rion Aesthetics | 84% | |
| Primoris International Co., Ltd. | 81% | |
| Kimera Labs | 80% |
For institutional investors. Book with your work email.
ExoCoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 25, 2020 | ||||
| Series B | Sep 12, 2018 | ||||
| Series A | May 4, 2017 |
For institutional investors. Book with your work email.
ExoCoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ID Ventures | Series A |
| InterVest | Series B |
| KDB Capital Corp | Series B |
| K2 Investment Partners | Series C, Series B |
| Csquared Global Asset Management | Series B |
| Focus Assets Management | Series C |
| TS Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2026
Named a finalist in four categories for the Cosmoprof Asia Awards 2026.
- Feb 22, 2026
Grew 23% QoQ, from 22 to 27 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asNov 6, 2026
Biotechnology company ExoCoBio Inc. secures finalist positions for ASCEplus EXOMIST Platinum HR in Hair Products, EXOPORIN-I in Home & Professional Devices and Tools, EXO-CC Cushion Platinum 21 in Make-up Products, and EXOMIST Platinum WR in Personal Care & Body Care.
- recognized_asNov 6, 2026
ExoCoBio Inc. is a finalist for EXOMIST Platinum WR in Personal Care & Body Care and secures multiple finalist positions across beauty categories.
For institutional investors. Book with your work email.
ExoCoBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExoCoBio's valuation, stock price, and market status.
Is ExoCoBio a public or private company?
ExoCoBio is a private company.
What is the current stock price of ExoCoBio?
ExoCoBio is a private company, so its shares have no public market price. Caplight tracks ExoCoBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExoCoBio worth (valuation)?
Valuation information for ExoCoBio is not publicly available.
Can I buy ExoCoBio stock?
ExoCoBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExoCoBio's last funding round?
ExoCoBio's most recent funding round was Series C on August 25, 2020.
Who are the main investors in ExoCoBio?
Key investors in ExoCoBio include ID Ventures, InterVest, KDB Capital Corp, K2 Investment Partners, Csquared Global Asset Management.
Will ExoCoBio IPO soon?
No public IPO plans have been announced for ExoCoBio.
How can I track ExoCoBio secondary market activity?
Caplight tracks bids, offers, and trades in ExoCoBio's shares on secondary markets.